169 related articles for article (PubMed ID: 20034558)
1. In vivo detection of inducible nitric oxide synthase in rodent gliomas.
Towner RA; Smith N; Doblas S; Garteiser P; Watanabe Y; He T; Saunders D; Herlea O; Silasi-Mansat R; Lupu F
Free Radic Biol Med; 2010 Mar; 48(5):691-703. PubMed ID: 20034558
[TBL] [Abstract][Full Text] [Related]
2. Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.
Towner RA; Smith N; Saunders D; De Souza PC; Henry L; Lupu F; Silasi-Mansat R; Ehrenshaft M; Mason RP; Gomez-Mejiba SE; Ramirez DC
Biochim Biophys Acta; 2013 Dec; 1832(12):2153-61. PubMed ID: 23959048
[TBL] [Abstract][Full Text] [Related]
3. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH
Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of c-Met expression in a rat C6 glioma model.
Towner RA; Smith N; Doblas S; Tesiram Y; Garteiser P; Saunders D; Cranford R; Silasi-Mansat R; Herlea O; Ivanciu L; Wu D; Lupu F
J Cell Mol Med; 2008; 12(1):174-86. PubMed ID: 18194445
[TBL] [Abstract][Full Text] [Related]
5. Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.
He T; Smith N; Saunders D; Pittman BP; Lerner M; Lightfoot S; Silasi-Mansat R; Lupu F; Towner RA
Am J Nucl Med Mol Imaging; 2013; 3(4):300-11. PubMed ID: 23901356
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
7. Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model.
Yamaguchi S; Bell HS; Shinoda J; Holmes MC; Wharton SB; Whittle IR
Br J Neurosurg; 2002 Dec; 16(6):567-72. PubMed ID: 12617238
[TBL] [Abstract][Full Text] [Related]
8. "Facilitated" amino acid transport is upregulated in brain tumors.
Miyagawa T; Oku T; Uehara H; Desai R; Beattie B; Tjuvajev J; Blasberg R
J Cereb Blood Flow Metab; 1998 May; 18(5):500-9. PubMed ID: 9591842
[TBL] [Abstract][Full Text] [Related]
9. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.
Isakovic A; Harhaji L; Dacevic M; Trajkovic V
Eur J Pharmacol; 2008 Sep; 591(1-3):106-13. PubMed ID: 18606162
[TBL] [Abstract][Full Text] [Related]
10. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
[TBL] [Abstract][Full Text] [Related]
12. The role of eNOS in vascular permeability in ENU-induced gliomas.
Bulnes S; Argandoña EG; Bengoetxea H; Leis O; Ortuzar N; Lafuente JV
Acta Neurochir Suppl; 2010; 106():277-82. PubMed ID: 19812964
[TBL] [Abstract][Full Text] [Related]
13. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells.
Shinoda J; McLaughlin KE; Bell HS; Swaroop GR; Yamaguchi S; Holmes MC; Whittle IR
Glia; 2003 Apr; 42(1):68-76. PubMed ID: 12594738
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
16. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
[TBL] [Abstract][Full Text] [Related]
17. OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.
Coutinho de Souza P; Smith N; Atolagbe O; Ziegler J; Njoku C; Lerner M; Ehrenshaft M; Mason RP; Meek B; Plafker SM; Saunders D; Mamedova N; Towner RA
Free Radic Biol Med; 2015 Oct; 87():157-68. PubMed ID: 26119786
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
[TBL] [Abstract][Full Text] [Related]
20. Models of monocytic invasion into glioma cell aggregates.
Strik HM; Hülper P; Erdlenbruch B; Meier J; Kowalewski A; Hemmerlein B; Gold R; Bähr M
Anticancer Res; 2006; 26(2A):865-71. PubMed ID: 16619481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
